Cullinan Oncology to sell Cullinan Pearl to Taiho Pharmaceutical for $275m

American biopharma company Cullinan Oncology has agreed to sell its subsidiary Cullinan Pearl to Taiho Pharmaceutical, a Japanese specialty pharma company, for $275 million. Cullinan ... Read More